retatrutide and semaglutide vs. semaglutide: A head-to-head comparison Retatrutide vs Semaglutide: Triple Agonist

A proof-of-concept study published in 2023 demonstrated an oral delivery system of modified GLP-1 using probiotic bacteria in animal models

Subtle volumisation with injectables is only introduced where truly needed

Overall the results of this study, which followed over 200,000 people with diabetes who were treated with GLP1RAs and compared them to over 1.5 million people on other forms of diabetes treatment, is reassuring regarding the risk/benefit ratio for the long term use of GLP1RAs in people with diabetes

Keep it refrigerated at 28C, protected from light, and within the window printed on its Certificate of Analysis